KPC Pharmaceuticals,Inc Stock price

Equities

600422

CNE0000015P8

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
21.15 CNY -1.54% Intraday chart for KPC Pharmaceuticals,Inc +2.03% +1.39%
Sales 2024 * 9.27B 1.28B Sales 2025 * 10.41B 1.44B Capitalization 16.01B 2.22B
Net income 2024 * 559M 77.36M Net income 2025 * 824M 114M EV / Sales 2024 * 1.73 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.54 x
P/E ratio 2024 *
28.6 x
P/E ratio 2025 *
19.4 x
Employees 5,051
Yield 2024 *
0.96%
Yield 2025 *
1.21%
Free-Float 58.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.54%
1 week+2.03%
Current month+5.43%
1 month+2.87%
3 months+3.52%
6 months+13.22%
Current year+1.39%
More quotes
1 week
20.30
Extreme 20.3
22.20
1 month
18.73
Extreme 18.73
22.20
Current year
17.26
Extreme 17.26
22.55
1 year
15.18
Extreme 15.18
26.09
3 years
8.05
Extreme 8.05
26.09
5 years
7.64
Extreme 7.64
26.09
10 years
5.95
Extreme 5.95
26.09
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 23-01-02
President 53 23-01-18
Director/Board Member 52 97-08-31
Members of the board TitleAgeSince
Chairman 57 23-01-18
Director/Board Member 53 23-10-17
Director/Board Member 48 99-06-30
More insiders
Date Price Change Volume
24-03-27 21.15 -1.54% 9,276,899
24-03-26 21.48 -0.23% 8,882,300
24-03-25 21.53 +1.13% 17,996,030
24-03-22 21.29 +3.10% 20,007,710
24-03-21 20.65 -0.39% 4,413,434

End-of-day quote Shanghai S.E., March 26, 2024

More quotes
KPC Pharmaceuticals, Inc. is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company's main products include natural herbal medicines, traditional Chinese medicines and chemical synthetic drugs, such as central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines and anti-inflammatory drugs, among others. The Company is also engaged in the production of health products and provision of medical services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
21.15 CNY
Average target price
26.91 CNY
Spread / Average Target
+27.23%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock KPC Pharmaceuticals,Inc - Shanghai S.E.